ADD I T I ONA L I NFORMAT I ON CON T I NU E D 2021 Salary/fees $ Bonus $ Super- annuation $ Share based payments $ Total $ Non-Executive Directors Patrick Davies 120,000 - - - 120,000 Dr Trevor Scott 72,000 - - - 72,000 Dianne Angus 54,670 - 5,330 - 60,000 Dr Jenny Harry 60,094 - 5,906 - 66,000 306,764 - 11,236 - 318,000 Executive Directors Jonathan Pilcher1 190,437 - 12,688 229,123 432,248 Total 497,201 - 23,924 229,123 750,248 1 The table for the year ended 31 December 2021 shows the total remuneration for Jon Pilcher since his appointment to Managing Director on 14 June 2021. Loan Funded Shares Jon Pilcher has an interest in 1,500,000 Loan Funded Shares held by Neuren Trustee Limited. As detailed in Note 12 to the Financial Statements, the Loan Funded Shares are subject to vesting conditions and repayment of a loan amounting to $1.84 per share before they can be transferred to Jon. EMPLOYEE REMUNERATION The number of employees, not being directors of the Company, who received remuneration and benefits in their capacity as employees totalling NZ $100,000 or more during the year, shown in bands denominated in Australian dollars, was as follows: Excluding share based payments 2022 $’000 2021 $’000 $150,000 - $159,999 1 - $160,000 - $169,999 - 1 $170,000 - $179,999 - 2 $190,000 - $199,999 1 - $240,000 - $249,999 2 - $270,000 - $279,999 1 1 $290,000 - $299,999 - 1 $300,000 - $309,999 1 - Including share based payments 2022 $’000 2021 $’000 $150,000 - $159,999 1 - $160,000 - $169,999 - 1 $170,000 - $179,999 - 1 $340,000 - $349,999 1 - $360,000 - $369,999 1 1 $390,000 - $399,999 1 - $400,000 - $409,999 1 - $480,000 - $489,999 - 1 $500,000 - $509,999 - 1 $640,000 - $649,999 1 - Neuren Pharmaceuticals Limited Annual Repor t 2022 49
RkJQdWJsaXNoZXIy MjE2NDg3